Table 4.
Variable | pCR |
pPR |
||
---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |
p valuea | p valueb | p valuea | p valueb | |
Gender | ns | – | ns | – |
Stage | ||||
II | p < 0.001 | ns | p < 0.001 | p < 0.001 |
III* | ||||
Dose* | p = 0.002 | ns | p = 0.01 | p = 0.006 |
Chemotherapy schedule | ||||
1 drug | ns | – | p = 0.04 | p = 0.01 |
2-drug* | ||||
Time interval* | p < 0.001 | p < 0.001 | p < 0.001 | p = 0.001 |
Significant p values (p value <= 0.05) are in bold.
Only variables with a p value ≤0.05 in the univariate logistic regression analysis were included in the multivariate model.
stage III, higher dose, 2-drug schedule and longer interval correlated with better pathological response. Dose and time interval were considered as continuous variables in the logistic regression analysis.